Research Area Tuberculosis

A5343: A Trial of the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, among Participants Taking Multidrug Treatment for Drug-Resistant Pulmonary Tuberculosis

This is a randomized study, which means, by chance, you will be in one of three groups. You have an…

Closed to accrual

24 weeks on study treatment, followed by 104 weeks follow-up, for a total length of 128 weeks

See locations